Oxford Gene Technology SureSeq CLL + CNV V3 Panel

Oxford Gene Technology has launched SureSeq CLL + CNV V3 Panel, an updated next-gen sequencing test for chronic lymphocytic leukemia research that offers more expansive coverage of disease-associated genes and enhanced CNV calling, resulting in more comprehensive variant detection. The new panel includes more targeted genes as well as increased probe density.